Completed Cells, Biochemistry & Physiology Diabetes, Hormones & Metabolism

Functional studies of the ATP-sensitive potassium channel.

In plain English

AI plain-English summary

A faulty ion channel in the pancreas can lock insulin production into a dangerous on-off cycle that leaves some newborns with diabetes. The channel, called KATP, normally acts as a metabolic sensor in cells, adjusting their electrical activity based on available energy. When mutations in the channel’s subunits—Kir6.2 and SUR1—make it overactive, the cell fails to release insulin, causing neonatal diabetes. In some patients the condition is permanent; in others it disappears only to return later in life. A few also develop neurological problems. This research aims to map exactly how the channel’s structure controls its gating—how it opens and closes in response to nucleotides and drugs—and how specific mutations disrupt that process. Using mouse models, the team will also explore three puzzles from human patients: why sulphonylurea drugs work better with oral glucose than intravenous glucose; why diabetes can remit and relapse; and why some mutations cause brain symptoms alongside diabetes. The work is fundamental science. It will not produce a new treatment tomorrow. But understanding the precise mechanics of KATP channels has already led to drug therapies for diabetes, and deeper knowledge of gating could eventually guide better drugs for neonatal diabetes and related metabolic disorders.

View original technical description
KATP channels play key roles in many cell types by coupling the metabolic state of the cell to its electrical activity. Gain-of-function mutations in the KATP channel subunits Kir6.2 and SUR1 cause human neonatal diabetes (ND). In some patients diabetes is permanent, but in others it is transient. A few patients also experience neurological symptoms. The overall goals of this research programme are to understand the relationship between KATP channel structure and function, and to elucidate its role in human neonatal diabetes. We will use an integrated multidisciplinary approach that encompasses studies at the protein, cell and organism level. Electrophysiology of heterologously expressed channels will be used to elucidate the relationship between KATP channel structure and function, focussing how gating is regulated by ligands such as nucleotides and drugs, and how this is affected by ND mutations. Mouse models will be used to investigate how ND mutations lead to diabetes, and t o address questions raised in humans studies. These include: why patients on sulphonylurea therapy respond better to oral glucose than intravenous glucose; why some patients have neonatal diabetes that remits early in life but relapses later; and why some mutations produce neurological symptoms in addition to diabetes.

View the original record at the funder ↗

Researchers

Frances Ashcroft (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Functional dynamics of the KATP channel
The role of the ATP-sensitive potassium channels in cardiovascular physiology and disease (renewal)
Regulation of KATP channel function
Regulation of endocytic trafficking of KATP channels by protein kinase C
Towards an understanding of the molecular mechanisms that underlie the function of vascular ATP-sensitive potassium (KATP) channels

Original classification

Programme Grant

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.